| RS1135401769 |
WAC
|
Health Risk |
Pathogenic |
DeSanto-Shinawi syndrome due to WAC point mutation, DeSanto-Shinawi syndrome due to WAC point mutation |
| RS1135401770 |
ZBTB18
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 22 |
| RS1135401771 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS1135401772 |
ATP6V1B2
|
Health Risk |
Likely pathogenic |
Zimmermann-Laband syndrome 2, Zimmermann-Laband syndrome 2 |
| RS1135401773 |
MAOA
|
Health Risk |
Likely pathogenic |
Brunner syndrome, Brunner syndrome |
| RS1135401776 |
KRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 3, Noonan syndrome 3 |
| RS1135401777 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS1135401778 |
BPTF
|
Health Risk |
Pathogenic |
Intellectual disability, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS1135401779 |
ZNF292
|
Health Risk |
Pathogenic |
Intellectual disability, Neurodevelopmental disorder |
| RS1135401784 |
CP
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of ferroxidase, Neurodegeneration with brain iron accumulation |
| RS1135401786 |
GABRB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 45 |
| RS1135401787 |
MAP2K2
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 4, Cardiofaciocutaneous syndrome 4 |
| RS1135401788 |
GRIA3
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 94, Syndromic X-linked intellectual disability 94 |
| RS1135401789 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1135401790 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1135401791 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS1135401792 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Inborn genetic diseases |
| RS1135401793 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Intellectual disability-hypotonic facies syndrome |
| RS1135401794 |
HNRNPU
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1135401795 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS1135401796 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1135401797 |
ZMYND11
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS1135401798 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1135401799 |
GRIN2B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS1135401800 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Inborn genetic diseases |
| RS1135401801 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS1135401802 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS1135401803 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1135401804 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1135401805 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1135401806 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1135401807 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1135401808 |
ADNP
|
Health Risk |
Pathogenic/Likely pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, Intellectual disability |
| RS1135401809 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1135401810 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1135401811 |
SCN2A
|
Health Risk |
Likely pathogenic |
Autism Spectrum Disorder with Intellectual Disability, Autism Spectrum Disorder with Intellectual Disability |
| RS1135401812 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS1135401813 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1135401814 |
MICU1
|
Health Risk |
Pathogenic |
Proximal myopathy with extrapyramidal signs, Proximal myopathy with extrapyramidal signs |
| RS1135401815 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1135401816 |
SOX5
|
Health Risk |
Likely pathogenic |
Lamb-Shaffer syndrome, Intellectual disability |
| RS1135401817 |
COG5
|
Health Risk |
Likely pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1135401818 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1135401819 |
STXBP1
|
Health Risk |
Likely pathogenic |
Non-syndromic intellectual disability, Non-syndromic intellectual disability |
| RS1135401820 |
FOXP2
|
Health Risk |
Likely pathogenic |
Childhood apraxia of speech, Childhood apraxia of speech |
| RS1135401821 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Intellectual disability |
| RS1135401822 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Dystonia 12 |
| RS1135401823 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1135401824 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1135401825 |
CIC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1135401826 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast and/or ovarian cancer |
| RS1135401827 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401829 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401832 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401833 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401834 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1135401836 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401837 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401838 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401839 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401840 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401841 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401843 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401844 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS1135401845 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401846 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401847 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401848 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401849 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401850 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401851 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401852 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401853 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401855 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401856 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401857 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401858 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401859 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401860 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401864 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401865 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401866 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401867 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401868 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401869 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401870 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401871 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401872 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1135401873 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401874 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401877 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401878 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401879 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401880 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401881 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401882 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401883 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401887 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1135401888 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1135401890 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |